Stockhead on MSN
Biocurious: By acquiring new assets, drug developers are hedging their bets on long and winding approval journey
Drug developers have been acquiring complimentary programs to reduce execution risk and maintain investor interest.
Through cutting-edge methods and advanced artificial intelligence analysis, UNC Charlotte researchers leading a ...
3don MSN
Discovery of viral entry routes and decoy molecules could block yellow fever and encephalitis
Researchers at Washington University School of Medicine in St. Louis have identified central routes that two deadly viruses take to invade human cells and have designed decoy molecules that block the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results